150 related articles for article (PubMed ID: 27731521)
21. Identifying the most appropriate age threshold for TNM stage grouping of well-differentiated thyroid cancer.
Hendrickson-Rebizant J; Sigvaldason H; Nason RW; Pathak KA
Eur J Surg Oncol; 2015 Aug; 41(8):1028-32. PubMed ID: 25986855
[TBL] [Abstract][Full Text] [Related]
22. Using the American Thyroid Association Risk-Stratification System to Refine and Individualize the American Joint Committee on Cancer Eighth Edition Disease-Specific Survival Estimates in Differentiated Thyroid Cancer.
Ghaznavi SA; Ganly I; Shaha AR; English C; Wills J; Tuttle RM
Thyroid; 2018 Oct; 28(10):1293-1300. PubMed ID: 29897011
[TBL] [Abstract][Full Text] [Related]
23. No significant difference in the prognostic value of the 5th and 7th editions of AJCC staging for differentiated thyroid cancer.
Vrachimis A; Gerss J; Stoyke M; Wittekind C; Maier T; Wenning C; Rahbar K; Schober O; Riemann B
Clin Endocrinol (Oxf); 2014 Jun; 80(6):911-7. PubMed ID: 24417487
[TBL] [Abstract][Full Text] [Related]
24. Reassessing the NTCTCS Staging Systems for Differentiated Thyroid Cancer, Including Age at Diagnosis.
McLeod DS; Jonklaas J; Brierley JD; Ain KB; Cooper DS; Fein HG; Haugen BR; Ladenson PW; Magner J; Ross DS; Skarulis MC; Steward DL; Xing M; Litofsky DR; Maxon HR; Sherman SI
Thyroid; 2015 Oct; 25(10):1097-105. PubMed ID: 26203804
[TBL] [Abstract][Full Text] [Related]
25. Optimal Cutoff Age for Predicting Mortality Associated with Differentiated Thyroid Cancer.
Kim SJ; Myong JP; Suh H; Lee KE; Youn YK
PLoS One; 2015; 10(6):e0130848. PubMed ID: 26102084
[TBL] [Abstract][Full Text] [Related]
26. An International Multi-Institutional Validation of Age 55 Years as a Cutoff for Risk Stratification in the AJCC/UICC Staging System for Well-Differentiated Thyroid Cancer.
Nixon IJ; Wang LY; Migliacci JC; Eskander A; Campbell MJ; Aniss A; Morris L; Vaisman F; Corbo R; Momesso D; Vaisman M; Carvalho A; Learoyd D; Leslie WD; Nason RW; Kuk D; Wreesmann V; Morris L; Palmer FL; Ganly I; Patel SG; Singh B; Tuttle RM; Shaha AR; Gönen M; Pathak KA; Shen WT; Sywak M; Kowalski L; Freeman J; Perrier N; Shah JP
Thyroid; 2016 Mar; 26(3):373-80. PubMed ID: 26914539
[TBL] [Abstract][Full Text] [Related]
27. Need for a revised staging consensus in medullary thyroid carcinoma.
Boostrom SY; Grant CS; Thompson GB; Farley DR; Richards ML; Hoskin TL; Hay ID
Arch Surg; 2009 Jul; 144(7):663-9. PubMed ID: 19620547
[TBL] [Abstract][Full Text] [Related]
28. Differentiated thyroid carcinoma presenting with distant metastasis at initial diagnosis clinical outcomes and prognostic factors.
Lee J; Soh EY
Ann Surg; 2010 Jan; 251(1):114-9. PubMed ID: 19779325
[TBL] [Abstract][Full Text] [Related]
29. Evaluating the use of a two-step age-based cutoff for the UICC/AJCC TNM staging system in patients with papillary or follicular thyroid cancer.
van Velsen EFS; Peeters RP; Stegenga MT; Mäder U; Reiners C; van Kemenade FJ; van Ginhoven TM; Visser WE; Verburg FA
Eur J Endocrinol; 2022 Feb; 186(3):389-397. PubMed ID: 35038308
[TBL] [Abstract][Full Text] [Related]
30. Application of staging systems for differentiated thyroid carcinoma in an endemic goiter region with iodine substitution.
Passler C; Prager G; Scheuba C; Kaserer K; Zettinig G; Niederle B
Ann Surg; 2003 Feb; 237(2):227-34. PubMed ID: 12560781
[TBL] [Abstract][Full Text] [Related]
31. Staging systems for papillary thyroid carcinoma: a study of 2 tertiary referral centers.
Lang BH; Chow SM; Lo CY; Law SC; Lam KY
Ann Surg; 2007 Jul; 246(1):114-21. PubMed ID: 17592299
[TBL] [Abstract][Full Text] [Related]
32. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of serum midkine as a biomarker in differentiated thyroid cancer.
Meng Z; Tan J; Zhang G; Tian W; Fu Q; Li W; He X; Wu S; Yang Z; Liang X; Dong L; Zhang Q; Liu L; Zhang Y; Xu K; Liu B; Li N; Li X; Jia Q; He Y; Wang S; Wang R; Zheng W; Song X; Zhang J; Hu T; Liu N; Upadhyaya A
Life Sci; 2015 Jun; 130():18-24. PubMed ID: 25817231
[TBL] [Abstract][Full Text] [Related]
34. Prognostic scoring systems in patients with follicular thyroid cancer: a comparison of different staging systems in predicting the patient outcome.
D'Avanzo A; Ituarte P; Treseler P; Kebebew E; Wu J; Wong M; Duh QY; Siperstein AE; Clark OH
Thyroid; 2004 Jun; 14(6):453-8. PubMed ID: 15242573
[TBL] [Abstract][Full Text] [Related]
35. Prospective study and proposal of an outcome predictive nomogram in a consecutive prospective series of differentiated thyroid cancer based on the new ATA risk categories and TNM.
Sapuppo G; Grasso S; Di Benedetto G; Belfiore A; Pellegriti G
Front Endocrinol (Lausanne); 2023; 14():1128963. PubMed ID: 36992807
[TBL] [Abstract][Full Text] [Related]
36. Evaluating Disease-specific Survival Prediction of Risk Stratification and TNM Systems in Differentiated Thyroid Cancer.
van Velsen EFS; Peeters RP; Stegenga MT; van Kemenade FJ; van Ginhoven TM; van Balkum M; Verburg FA; Visser WE
J Clin Endocrinol Metab; 2023 May; 108(6):e267-e274. PubMed ID: 36508298
[TBL] [Abstract][Full Text] [Related]
37. A critical analysis of the current TNM classification for differentiated thyroid carcinoma in young patients: Time for a change?
Wang W; Bai N; Li X
Front Endocrinol (Lausanne); 2022; 13():939131. PubMed ID: 36339438
[TBL] [Abstract][Full Text] [Related]
38. Ongoing risk stratification for differentiated thyroid cancer (DTC) - stimulated serum thyroglobulin (Tg) before radioiodine (RAI) ablation, the most potent risk factor of cancer recurrence in M0 patients.
Krajewska J; Jarząb M; Czarniecka A; Roskosz J; Kukulska A; Handkiewicz-Junak D; Puch Z; Wygoda Z; Paliczka-Cieślik E; Kropińska A; Gubała E; Jurecka-Lubieniecka B; Jarząb B
Endokrynol Pol; 2016; 67(1):2-11. PubMed ID: 26884109
[TBL] [Abstract][Full Text] [Related]
39. Staging systems for follicular thyroid carcinoma: application to 171 consecutive patients treated in a tertiary referral centre.
Lang BH; Lo CY; Chan WF; Lam KY; Wan KY
Endocr Relat Cancer; 2007 Mar; 14(1):29-42. PubMed ID: 17395973
[TBL] [Abstract][Full Text] [Related]
40. Decreasing Disease-Specific Mortality of Differentiated Thyroid Cancer in Korea: A Multicenter Cohort Study.
Jeon MJ; Kim HK; Kim EH; Kim ES; Yi HS; Kim TY; Kang HC; Shong YK; Kim WB; Kim BH; Kim WG
Thyroid; 2018 Sep; 28(9):1121-1127. PubMed ID: 29897005
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
